The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate Journal Article

Local Library Link: Find It @ Loyola

Authors: Guedj, J; Dahari, H; Uprichard, S. L.; Perelson, A. S.
Article Title: The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate
Journal Title: Expert review of gastroenterology hepatology
Volume: 7
Issue: 5
ISSN: 1747-4132; 1747-4124
Publisher: Unknown  
Journal Place: England
Date Published: 2013
Start Page: 397
End Page: 399
Language: eng
DOI/URL:

10.1586/17474124.2013.811050
Notes: LR: 20150417; GR: AI028433/AI/NIAID NIH HHS/United States; GR: HL109334/HL/NHLBI NIH HHS/United States; GR: OD011095/OD/NIH HHS/United States; GR: P20-GM103452/GM/NIGMS NIH HHS/United States; GR: R01 AI028433/AI/NIAID NIH HHS/United States; GR: R01 AI078881/AI/NIAID NIH HHS/United States; GR: R01 OD011095/OD/NIH HHS/United States; GR: R56/R01-AI078881/AI/NIAID NIH HHS/United States; JID: 101278199; 0 (Antiviral Agents); 0 (BMS-790052); 0 (Enzyme Inhibitors); 0 (Imidazoles); 0 (NS-5 protein, hepatitis C virus); 0 (Viral Nonstructural Proteins); NIHMS585897; OID: NLM: NIHMS585897; OID: NLM: PMC4067513; ppublish